“The same process will be used for the GenChoice! and GenPrecis! products as well as the Company’s recent projects, its GenAccord! and GenCambre! gluscose test strips specifically designed to run on legacy meters, in each case beginning with the 510k approval process with the FDA expected to commence during the early part of 2019“
Very nice
GoDECN!
(1)
(0)
Decision Diagnostics Corp (DECN) Stock Research Links